Wegovy Switzerland insurance 2026: stopped even if it works
The weight-loss injection is on the health insurers’ list. That is true, and it is only half the story. Anyone who gets it covered races against a clock: target weight after 16 weeks, after 10 months, a check every 6 months. Miss a target and cover ends. Go too far and it ends too.
💉 Weight-loss injection insurance: the 9 conditions
“The doctor prescribes, the insurer pays” does not apply to the weight-loss injection. The list of pharmaceutical specialities sets 9 conditions, and the last four only decide during treatment whether it continues.
| Condition | What the list requires |
|---|---|
| 1 · BMI | 35 or more, or 28 or more with prediabetes or type 2 diabetes, high blood pressure or dyslipidaemia (high blood lipids) |
| 2 · Prior approval | before starting, after consulting the insurer’s medical adviser |
| 3 · Documented diet | deficit of 500 kcal a day, confirmed to the insurer |
| 4 · Dietary counselling | alongside, with more physical activity that is documented (e.g. step counter) |
| 5 · Specialist in person | endocrinology with ≥ 100 obesity patients a year or a centre with ≥ 300 |
| 6 · Target week 16 | at least −5% (BMI 28–35) or −7% (from 35) |
| 7 · Target month 10 | at least −10% or −12%, then new approval |
| 8 · Maximum duration | 3 years, check every 6 months |
| 9 · Lower limit | stop once BMI is below 25 |
The rules are identical for Wegovy (semaglutide) and Mounjaro (tirzepatide). No combinations: not with a second medicine of this class, nor with insulin or other weight-loss drugs. On every pack the insured person pays a 10% co-payment, plus the deductible.
The deductible that goes with this co-payment can only be changed until 30 November: Cancel health insurance, deadline and template.
🔁 Ozempic or Wegovy: same active substance, CHF 1.25 apart
Same basic insurance, a different premium in every canton: where do you pay least?Switching health insurer: premiums and deductibles by cantonOzempic and Wegovy contain the same active substance, semaglutide. A pack for four weeks costs CHF 175.70 against CHF 176.95, according to the list. For diabetes the insurer pays without prior approval and without an end date; for weight loss, 3 years at most.
| Ozempic (type 2 diabetes) | Wegovy (weight loss) | |
|---|---|---|
| Active substance | semaglutide | semaglutide |
| Price per 4 weeks | CHF 175.70 (2 mg) | CHF 176.95 (up to 2.4 mg) |
| Prior approval | no | yes, after medical adviser |
| Who prescribes | any doctor | only specialist or centre, in person |
| Target weight | none | −5/7% after 16 weeks, −10/12% after 10 months |
| Maximum duration | none | 3 years |
| Valid until | no limit | 28 February 2027 |
People with insufficiently controlled type 2 diabetes get Ozempic from a BMI of 28 through basic insurance. An additional weight-loss drug is then expressly not covered. The dose differs: Ozempic up to 2 mg a week, Wegovy up to 2.4 mg.
Ozempic and Wegovy: same active substance, CHF 1.25 apart. For diabetes insurers pay without limit, for weight loss 3 years at most.
What is authorised against diabetes and what was only tested on mice: Is diabetes curable? The 2026 breakthroughs checked.
Ozempic, Mounjaro, stem cells: what is authorised against diabetes and what is only tested?Can diabetes be cured? The 2026 breakthroughs checked📏 Wegovy insurance BMI: authorised from 30, covered from 35
Swissmedic authorised Wegovy on 15 February 2022 from a BMI of 30, or 27 with a related condition. The insurer only pays from 35, or 28 with a related condition. In between, the medicine can be prescribed, but patients pay themselves.
A year of Wegovy costs CHF 2300.35 at list price (13 packs at CHF 176.95, ConvivaPlus calculation). Comparing it with the older drug Xenical, the FOPH itself had calculated an ex-factory price of CHF 90.58; today CHF 147.61 is paid, because the FOPH gives half the weight to prices abroad.
Regardless of the injection, the premium is worth a look: Switch health insurer shows by canton what is possible with the same basic insurance.
Medical costs you pay yourself belong in your tax return: at federal level, what exceeds 5% of income after deductions is deductible (Art. 33 DBG).
⏱️ Insurance stopwatch: the weight targets the insurer sets
The insurer does not count in kilos but in per cent of the starting weight. At 120 kg and a BMI above 35, that means at most 111.6 kg after 16 weeks and at most 105.6 kg after 10 months.
The ConvivaPlus insurance stopwatch calculates the targets of the list from weight and height at the start: target after 16 weeks, target after 10 months, and the weight at BMI 25, where cover also stops.
The BMI threshold of the list is reached. Prior approval, a documented diet, dietary counselling and a specialist in person are also required.
Then a check every 6 months, 3 years at most in total.
Rules of the FOPH list of pharmaceutical specialities (Wegovy, Mounjaro), as of 19.11.2026. Calculated with the ConvivaPlus insurance stopwatch.
🎯 Stopped if successful: cover ends before the finish line
Anyone receiving the injection on insurance may not lose weight without limit. In the list’s rules (paraphrased from the official German, French and Italian): treatment must also be stopped as soon as a BMI below 25 kg/m² is reached.
Paraphrased from the official German, French and Italian: treatment must also be stopped as soon as a BMI below 25 kg/m² is reached (FOPH list, Wegovy and Mounjaro; already so when Wegovy was listed in 2024).
If BMI later rises above 25 again, treatment may restart, but only within the 3 years counted from the first start. Anyone who regains weight above the 10-month target also loses cover. Anyone who misses the 16-week target on the first attempt is in principle excluded from cover for a restart, so in principle for good.
Insurers stop the injection below BMI 25. Fair?
One click – anonymous, no sign-up required.
🩺 Who can prescribe: specialists only, in person
In the May 2025 version, a specialist title in endocrinology/diabetology was enough to prescribe the injection on insurance. Since 1 December 2025 it no longer is: prescription and checks may only take place in person, with endocrinologists treating at least 100 obesity patients a year or at a centre treating at least 300.
Coordination via online services or online practices is excluded (ConvivaPlus paraphrase of the German original).
Online practices are thus out. People already in treatment were given, on the FOPH’s recommendation, a transition period until 31 May 2026. A family practice alone was never enough: general internal medicine specialists may only prescribe at a recognised obesity centre. A centre needs two specialists from two disciplines (endocrinology, general internal medicine, visceral surgery), dietary counselling on site or in a fixed partnership, and a network with psychiatry or psychology, physiotherapy and a bariatric centre.
💸 Mounjaro insurance Switzerland: up to CHF 388.40 a month, secret rebate
Mounjaro has been on the list since 1 January 2026, on the same conditions as Wegovy. At the highest dose, a pack for four weeks costs CHF 388.40, 2.2 times Wegovy. What the insurer really pays in the end appears in no public list.
According to the list, the manufacturer refunds the insurer a fixed share of the ex-factory price for every pack and discloses the amount only to the insurer. List prices: CHF 223.80 (2.5 and 5 mg), CHF 303.25 (7.5 and 10 mg), CHF 388.40 (12.5 and 15 mg). One year at the highest dose: CHF 5049.20 (ConvivaPlus calculation).
10% co-payment plus deductible: until when can you switch for 2027?Cancelling health insurance: 30 November deadline, template and deductible choice📅 Limited to 2027: cover has an expiry date
The adult rules for Wegovy apply until 28 February 2027. When it was first listed in 2024, the FOPH already limited the listing to 28 February 2027.
The rule that makes insurers stop after 3 years was itself only given three years: listed on 1 March 2024, limited to 28 February 2027. By then the manufacturer must file a complete new application; the FOPH will reassess efficacy, appropriateness and cost-effectiveness. For Mounjaro the deadline is 31 December 2027. Saxenda, the older drug still mentioned in the rules, is no longer on the list (checked 19 November 2026).
The listing is limited to 28 February 2027, the FOPH wrote in 2024 (ConvivaPlus paraphrase of the German original).
🧒 Teenagers from 12: 28 weeks to show results
For a 14-year-old boy, the insurance threshold is not a BMI of 35 but 32.98, for a girl of the same age 33.78: the list uses its own table for teenagers from 12. If BMI has not improved by 5% after 28 weeks, treatment is stopped and a restart is not covered.
Start at 15 and it is over at 18: the 3 years count in total, beyond the 18th birthday. Minimum weight 60 kg. Only paediatricians specialised in endocrinology-diabetology, heads of recognised therapy programmes or paediatric obesity reference centres may prescribe. Checks at least every 3 months.
📊 Overweight Switzerland: 43% of the population
How many people reach the insurance threshold of BMI 35, nobody in Switzerland knows: the federal health survey only counts obesity from BMI 30. What is known: 12% of the population aged 15+ are obese, 43% overweight or obese (31% + 12%, FSO, 2022).
The share of people with obesity has more than doubled: 5% in 1992, 12% in 2022 (FSO). A study commissioned by the FOPH puts the health costs of conditions linked to overweight and obesity at CHF 3.7 billion in 2022. For comparison: a year of Wegovy costs CHF 2300.35 per person at list price.
❓ Frequently asked questions
Weight-loss injection and Swiss health insurance: the most common questions, answered with the FOPH list of pharmaceutical specialities.
People also ask
Related questions from our magazine
Basic insurance covers the same everywhere, but premiums differ by canton and insurer by several hundred francs a year. The comparison by canton is on the premiums page.
Basic insurance can be switched for the end of the year; the cancellation must reach the insurer by 30 November. Template and deductible choice are on the cancellation page.
Not today: according to the FOPH, type 1 diabetes has so far been incurable. Behind the breakthrough headlines are studies on mice, on one person or on twelve, none authorised in Switzerland.
Read next
Sourced sentence by sentence · checked against the sources · researched with the help of artificial intelligence · How we work ›
ConvivaPlus EditorialEditorial ›All information without guarantee. Found an error? → support@conviva-plus.ch
Found an error or have feedback? Let us know or write to us directly.
